Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Statistics
  • Help & Advice
University of Warwick

The Library

  • Login

Sequence-dependent oligomerization of the neu transmembrane domain suggests inhibition of "conformational switching" by an oncogenic mutant

Tools
- Tools
+ Tools

Beevers, Andrew J., Damianoglou, Angeliki, Oates, Joanne, Rodger, Alison and Dixon, Ann M.. (2010) Sequence-dependent oligomerization of the neu transmembrane domain suggests inhibition of "conformational switching" by an oncogenic mutant. Biochemistry, Vol.49 (No.13). pp. 2811-2820. ISSN 0006-2960

Full text not available from this repository.
Official URL: http://dx.doi.org/10.1021/bi902087v

Abstract

Membrane-spanning epidermal growth factor receptor ErbB2 is of key importance in cell division, in which a dimeric complex of the protein is responsible for tyrosine kinase activation following ligand binding. The rat homologue of this receptor (Neu) is prone to a valine to glutamic acid mutation in the transmembrane domain (TM), resulting in permanent activation and oncogenesis. In this study, the TM domains of Neu and the corresponding oncogenic mutant Neu*, which contains a V to E mutation at position 664 in the TM domain, have been analyzed to improve our understanding of the structural effects of the oncogenic V664E mutation. Building on previous work, we have focused here on understanding the sequence dependence of TM helix helix interactions and any differences in behavior upon introduction of the V664E mutation. Using a variety of biochemical and biophysical methods, we find that the rat Neu TM domain forms strong oligomers and, similar to previous observations for the human ErbB2 TM domain, the oncogenic mutation results in a reduced level of self-association. Our data also strongly indicate that the proto-oncogenic Neu TM domain can adopt multiple (at least two) oligomeric conformations in the membrane, possibly corresponding to the active and inactive forms of the receptor, and can "switch" between the two. Further, the oncogenic Neu* mutant appears to inhibit this "conformational switching" of TM dimers, as we observe that dimerization of the Neu* TM domain in the Escherichia coli inner membrane strongly favors a single conformation stabilized by an I XXXV motif (I-659-XXX-V-663) originally identified by site-specific infrared spectroscopic studies.

Item Type: Journal Article
Subjects: Q Science > QD Chemistry
R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
Divisions: Faculty of Science > Chemistry
Library of Congress Subject Headings (LCSH): Oncogenes, Oligomers, Conformational analysis, Cell receptors
Journal or Publication Title: Biochemistry
Publisher: American Chemical Society
ISSN: 0006-2960
Date: 6 April 2010
Volume: Vol.49
Number: No.13
Number of Pages: 10
Page Range: pp. 2811-2820
Identification Number: 10.1021/bi902087v
Status: Peer Reviewed
Publication Status: Published
Access rights to Published version: Restricted or Subscription Access
Funder: Medical Research Council (Great Britain) (MRC)
Grant number: 00601114 (MRC)
URI: http://wrap.warwick.ac.uk/id/eprint/6210

Data sourced from Thomson Reuters' Web of Knowledge

Request changes to a record

Actions (login required)

View Item View Item
twitter

Email us: publications@warwick.ac.uk
Contact Details
About Us